The AI Eye: Accenture (NYSE: ACN) to Acquire Cirruseo, NVIDIA (NASDAQ: NVDA) and Nuance (NASDAQ: NUAN) Working with American College of Radiology to Leverage AI in Diagnostics
Point Roberts, WA and Vancouver, BC - April 9, 2019 (Investorideas.com Newswire) Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.
Listen to today's podcast:
The #AI Eye: Accenture (NYSE: $ACN) to Acquire Cirruseo, NVIDIA (NASDAQ: $NVDA) and Nuance (NASDAQ: $NUAN) Working with American College of Radiology to Leverage AI in Diagnostics
Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence
Accenture (NYSE:ACN) has entered negotiations to acquire Google Cloud services provider Cirruseo. The acquisition would allow Accenture to better assist clients in leveraging Google Cloud technologies in an industry-specific context, including artificial intelligence solutions such as data analytics and machine learning tools. Olivier Girard, Accenture’s Geographic Unit managing director for France and Benelux, commented:
“The addition of Cirruseo would be a significant step forward in our growth strategy in France, bringing a strong team of Google Cloud specialists to Accenture. The combination of Cirruseo’s mastery of Google Cloud technologies with our expertise in digital marketing, artificial intelligence and cybersecurity would enhance our ability to deliver a unique end-to-end service offering to help clients with their digital transformations.”
NVIDIA Corporation (NasdaqGS:NVDA) has announced a collaboration with the American College of Radiology (ACR) to accelerate AI adoption in a diagnostic capacity. The ACR AI-Lab will integrate the NVIDIA Clara AI toolkit, which is a platform to create data and algorithm pipelines. Bibb Allen Jr., M.D., FACR and chief medical officer of the Data Science Institute at the ACR, explained:
“This collaboration marks a significant milestone in an extraordinary ACR Data Science Institute project, helping enable the launch of the ACR AI-LAB, giving radiologists in any practice environment an opportunity to become involved in AI development at their own institutions, using their own patient data to meet their own clinical needs.”
Also supporting the ACR AI-Lab is Nuance Communications, Inc. (NasdaqGS:NUAN) and their Nuance AI Marketplace, which is powered by NVIDIA Clara. Karen Holzberger, vice president and general manager of Healthcare Diagnostics at Nuance, commented:
“Combining the strength of the NVIDIA Clara AI platform with the scale of the Nuance AI Marketplace for Diagnostic Imaging will empower ACR AI-LAB developers to rapidly build and seamlessly deploy AI algorithms into the existing clinical workflows of over 70 percent of all radiologists across more than 5,800 connected healthcare facilities.”
Global AI Wearable Market to Hit $251.62 Billion by 2026
A report from Data Bridge Market Research finds that the global AI wearable market will grow from $11.5 billion in 2018 to an estimated $251.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 29.20 percent in the forecast period 2019-2026. An excerpt from the report description reads:
Wearable AI is often used to track a person’s vital signs of data those are related to location, health and fitness or even one’s biofeedback indicating emotion. Although it has some issues like privacy and the extent to which they may affect the way of social interaction and how the person looks wearing them and the issues with user-friendliness, it is being used by millions of users worldwide from smartwatches to fitness trackers, ring and bracelets, even smart glasses.
Sam Mowers, Investorideas.com
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts, articles, podcasts and videos talking about cannabis, crypto, technology including AI and IoT, mining, sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, contents creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp
Learn more about our podcast and article services and costs https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country.
The AI Eye -Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
800 665 0411